Stability of response characteristics of a Delphi panel: application of bootstrap data expansion by Akins, Ralitsa B et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Medical Research 
Methodology
Open Access Research article
Stability of response characteristics of a Delphi panel: application of 
bootstrap data expansion
Ralitsa B Akins*1, Homer Tolson2 and Bryan R Cole2
Address: 1Quality and Patient Safety Initiatives, Rural and Community Health Institute, The Texas A&M University System Health Science Center, 
College Station, Texas, USA and 2Department of Educational Administration and Human Resource Development, The Texas A&M University, 
College Station, Texas, USA
Email: Ralitsa B Akins* - ralitsa_akins@yahoo.com; Homer Tolson - htolson@tamu.edu; Bryan R Cole - b-cole@tamu.edu
* Corresponding author    
Abstract
Background: Delphi surveys with panels of experts in a particular area of interest have been
widely utilized in the fields of clinical medicine, nursing practice, medical education and healthcare
services. Despite this wide applicability of the Delphi methodology, there is no clear identification
of what constitutes a sufficient number of Delphi survey participants to ensure stability of results.
Methods: The study analyzed the response characteristics from the first round of a Delphi survey
conducted with 23 experts in healthcare quality and patient safety. The panel members had similar
training and subject matter understanding of the Malcolm Baldrige Criteria for Performance
Excellence in Healthcare. The raw data from the first round sampling, which usually contains the
largest diversity of responses, were augmented via bootstrap sampling to obtain computer-
generated results for two larger samples obtained by sampling with replacement. Response
characteristics (mean, trimmed mean, standard deviation and 95% confidence intervals) for 54
survey items were compared for the responses of the 23 actual study participants and two
computer-generated samples of 1000 and 2000 resampling iterations.
Results: The results from this study indicate that the response characteristics of a small expert
panel in a well-defined knowledge area are stable in light of augmented sampling.
Conclusion: Panels of similarly trained experts (who possess a general understanding in the field
of interest) provide effective and reliable utilization of a small sample from a limited number of
experts in a field of study to develop reliable criteria that inform judgment and support effective
decision-making.
Background
Since its development in the 1950's, the Delphi method
has been broadly utilized in various fields of study includ-
ing clinical medicine, nursing practice, medical education
and healthcare services [1,2]. Despite its wide application,
however, many questions regarding this methodology
still continue to intrigue researchers. One such question is
whether small expert samples are sufficient to conduct a
Delphi study; sufficient in this case refers to the stability of
panel responses.
In this methodological paper, the adequacy of utilization
of a small number of experts in a Delphi panel is dis-
cussed. Computer software (SPSS 12.5) was used to aug-
Published: 01 December 2005
BMC Medical Research Methodology 2005, 5:37 doi:10.1186/1471-2288-5-37
Received: 22 July 2005
Accepted: 01 December 2005
This article is available from: http://www.biomedcentral.com/1471-2288/5/37
© 2005 Akins et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
Page 2 of 12
(page number not for citation purposes)
ment the data from the first round of a Delphi survey
conducted with 23 healthcare quality and patient safety
experts and to study the similarities and differences
between the response characteristics of the original data
and the computer-generated samples.
Sample size in delphi studies
There is no agreement on the panel size for Delphi stud-
ies, nor recommendation or unequivocal definition of
"small" or "large" samples [1-3]. There is a lack of agree-
ment around the expert sample size and no criteria against
which a sample size choice could be judged. Studies have
been conducted with virtually any panel size. Reid (1988)
studied published articles on Delphi applications in
healthcare and noted that there were from 10 to 1685
panellists utilized [4]. Delphi studies with fewer than 10
participants are rarely conducted. For example, a panel of
only 5 experts was asked to identify serious drug interac-
tions most likely to occur in the ambulatory pharmacy set-
ting [5], and the responses of an international panel of 6
experts were used to explore competence training for pri-
mary care nurses [6]. Many published Delphi studies use
panels consisting of 10 to 100 or more panellists, as dem-
onstrated by the following examples. A panel of 10 experts
evaluated stage-tailored health promoting interventions
[7], and 13 experts were utilized in studying a variety of
skills in young children [8]. Two expert panels, consisting
of 18 regional and 52 national experts respectively, partic-
ipated in evaluating an existing pain evaluation system
[9]. A multidisciplinary group of 23 participants devel-
oped recommendations for the treatment of gastro-
esophageal reflux disease [10]. Thirty participants were
utilized to examine the factors impacting the effectiveness
of continuing education in long-term healthcare environ-
ment [11] and 32 experts identified the types of scientific
misconduct most likely to influence the results of a clini-
cal trial, such as selective reporting and opportunistic use
of the play of chance [12]. Two separate studies used a
panel of 60 individuals to explore issues of nurse leader-
ship in primary care and priorities in cancer nursing
research, respectively [13,14]. Sixty-four medical educa-
tors participated in a Delphi panel to develop guidelines
for bioterrorism curricula for medical students [15]. One
hundred and ten panellists participated in identification
of health areas with consumer involvement in research
[16], and another panel of 110 pharmacists identified
challenges for pharmacy executives [17]. A Delphi panel
of 199 nurses explored paediatric oncology nurses' per-
ceptions of parent educational needs [18]. The University
of Virginia used 421 respondents in one Delphi study
[19]. In another Delphi study, 2,865 participants were
invited to participate and 1,142 returned their question-
naires [20].
The sample size in Delphi studies has been researcher and
situation specific, and more often than not, convenience
samples have been chosen dependent on availability of
experts and resources. Given the lack of any Delphi sam-
ple size standards, there is confusion regarding how small
a "small" sample can be. For example, in one Delphi
study, a sample of 37 participants was considered too
small for a definite conclusion [21]. In general, the confu-
sion around the Delphi sample arises from the fact that
there are no standards established in any methodologi-
cally acceptable way. The current literature presents only
empirical choices on Delphi expert sample sizes made by
individual researchers, such as convenience, purposive or
criterion sampling [22].
Malcolm Baldrige award criteria for performance 
excellence in healthcare
The Malcolm Baldrige National Quality Award (MBNQA)
was established in 1987 and is the most prestigious
national quality award in the U.S. It is given by the United
States Department of Commerce under the authority of
the Malcolm Baldrige National Quality Improvement Act
of 1987. The MBNQA recognizes superior continuous
improvement programs focused on achieving and sustain-
ing performance excellence for the long term.
The MBNQA framework consists of core values and con-
cepts embodied in seven criteria categories: (1) Leader-
ship; (2) Strategic planning; (3) Focus on patients, other
customers and markets; (4) Measurement, analysis and
knowledge management; (5) Staff focus; (6) Process man-
agement; and (7) Organizational performance results
[25]. Although the criteria are results-oriented, they are
non-prescriptive and adaptable, so that organizational
structure and quality approaches may differ widely from
one organization to another. The flexibility and adaptabil-
ity of the Baldrige framework allow improvement changes
and objective assessment of an organization's quest for
quality.
The MBNQA has five sector categories: Manufacturing,
Service, Small Business, Education, and Healthcare. The
category of healthcare was added in 1998. Eligible appli-
cants in the category of healthcare include hospitals,
health maintenance organizations, long-term healthcare
facilities, healthcare practitioner offices, home health
agencies, and dialysis and ambulatory surgery centers.
Healthcare experts familiar with the MBNQA approaches
are best suited to offer a systems approach. Therefore,
their similar training, knowledge and understanding were
targeted influences for the outcomes of the Delphi survey.
The Malcolm Baldrige criteria provided a structured
approach for producing results within a proven frame-
work. Knowledge of the intricate details of the frameworkBMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
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ensured an advantage in its application to the field of
patient safety.
Importance of the study findings
The results from the analysis of and the comparison
between the original responses of the expert panel and the
computer generated samples indicated that the number of
selected experts utilized in this panel was sufficient to
insure reliability for a Delphi study in the field of interest.
This finding is important because it establishes the stabil-
ity of the results from a Delphi survey conducted with a
small number of experts from a defined field of study. We
can hypothesize that Delphi surveys with a similar
number of experts with similar training and knowledge in
other fields of study would also yield stable results. Addi-
tionally, this finding is important for practitioners in the
field of quality training, showing that individuals with
similar training, knowledge and understanding of the sys-
tems approach based on the Malcolm Baldrige quality cri-
teria could be utilized in a Delphi panel with a constricted
number of experts. Given the fact that specialized experts
in a given field may be limited, the results of this study
suggest that utilization of a small expert sample from lim-
ited numbers of experts in a field of study may be used
with confidence.
Methods
The Delphi method
The Delphi method facilitates communication between
and among a panel of experts, so that the process is effec-
tive and the group as a whole can deal with a complex
problem [26]. This method improves the generation of
critical ideas by structured collection of information and
processing of the collective input from a panel of geo-
graphically dispersed experts [27]. The methodology orig-
inated in the early 1950's, when an Air Force-sponsored
Rand project, titled "Project Delphi" sought to reach con-
sensus, through a series of questionnaires and controlled
feedback, among military experts on possible U.S. indus-
trial targets for attacks from Russia [26]. The Delphi meth-
odology has applications in many fields, including
healthcare, education and sociology.
The advantages of the method are numerous and include:
• The ability to conduct a study in geographically dis-
persed locations without physically bringing the respond-
ents together;
• Time and cost-effectiveness;
• Discussion of broad and complex problems;
• The ability for a group of experts with no prior history of
communication with one another to effectively discuss a
problem as a group;
• Participants can have sufficient time to synthesize their
ideas;
• Participants can respond at their convenience;
• There is a record of the group activity that can be further
reviewed;
• The anonymity of participants provides them with the
opportunity to freely express opinions and positions;
• The process has proven to be effective in a variety of
fields, problems, and situations [28].
Researchers use the Delphi method to translate scientific
knowledge and professional experience into informed
judgment, and support effective decision-making [22].
For subject matters in which the best available informa-
tion is the judgment of knowledgeable individuals, the
Delphi method has demonstrated decision-making
advantages over traditional conferences, group discus-
sions, brainstorming, and other interactive group activi-
ties. The focus in a Delphi study is on the stability of the
group opinion rather than on individuals' opinions, thus
measuring the group result is superior to measuring indi-
vidual rankings [27].
Healthcare Delphi survey
A Delphi survey with 23 experts from 18 US states was
conducted to create a patient safety tool to guide patient
safety improvement in US healthcare organizations. The
MBNQA framework was used as a general matrix for the
tool and was extended to the field of patient safety. The
Delphi study was reviewed and approved by the Institu-
tional Review Board – Human Subjects in Research at
Texas A&M University (protocol # 2003–0071).
The MBNQA examiners are trained to have in-depth
knowledge and extensive experience relevant to the seven
Baldrige categories in at least one, and preferably more
than one industry or service sector. Consequently, it was
important that the Delphi panel members had expertise
in the application of the Baldrige process, as well as in
patient safety systems.
Study sample size selection
Given that the intent of the Delphi survey was to examine
the patient safety systems in the context of a nationally
accepted management framework (the Malcolm Baldrige
National Quality Award Criteria for Performance Excel-
lence in Healthcare), all study experts were selected usingBMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
Page 4 of 12
(page number not for citation purposes)
stringent criteria, including knowledge of and/or training
in the Malcolm Baldrige Criteria for Performance Excel-
lence in Healthcare, and knowledge and experience in
patient safety. The number of experts with such qualifica-
tions was fairly limited (n ~ 100) and the sample of Del-
phi panel participants was small (n = 23).
The sample size for the study was based initially on an
empirically selected small sample size (n = 15) and the
expected response rate necessary to achieve this sample
size. It was critical to consider what response rate was usu-
ally obtained in surveys in the particular study area
(healthcare quality and patient safety). A survey on the
quality of healthcare and the problem of medical errors
administered to a large random sample of Colorado phy-
sicians, national physicians and Colorado households,
revealed response rates of 66% for the Colorado physician
sample, 36% for the national physician sample, and 82%
for the Colorado household sample [23]. The psychomet-
ric validation process for the Safety Attitude Question-
naire conducted in 160 healthcare sites in the U.S.,
England and New Zealand obtained a response rate of
67% [24]. Sumsion (1998), as discussed by Hasson,
Keeney and McKenna (2000), argued that in order to
maintain the rigor of the Delphi technique, a response
rate of 70% must be maintained [22]. Based on the
healthcare study response rates as found in the literature,
it was concluded that for this study a response rate of 70%
could be expected. Thus, to obtain at least 15 respondents,
the study should begin with 22–23 Delphi panellists,
where a sample size of 15 to 23 respondents was consid-
ered to be small. Responses were obtained from all 23
experts that had made a commitment to serve on the Del-
phi panel.
Selection of Delphi experts
Delphi participants are not selected randomly; rather,
they are purposefully selected to apply their knowledge
and experience to a certain issue based on criteria, which
are developed from the nature of the problem under
investigation. The following criteria were utilized to qual-
ify experts in healthcare quality improvement and patient
safety for inclusion in the original Delphi panel:
(a) Judges, senior examiners or examiners for the Malcolm
Baldrige National Quality Award in healthcare;
(b) Senior administrators in healthcare institutions that
have won or have applied for the Malcolm Baldrige
National Quality Award in healthcare;
(c) Senior administrators in healthcare institutions that
have won a state quality award within the last five calen-
dar years;
(d) Leaders in state or national organizations or programs
that emphasize continuous quality improvement and/or
patient safety;
(e) Experts possessing more than one of the aforemen-
tioned criteria.
Based on these criteria, only about 100 healthcare experts
nationwide qualified for participation in the Delphi
panel. Barriers to identification and inclusion of experts
were the confidentiality of MBNQA applicant names and
the scarcity of healthcare quality award winners at a state
level. Approximately one quarter of the qualified experts
were recruited for participation in the panel.
Since the names of the healthcare institutions, which have
applied for the Malcolm Baldrige Award are kept confi-
dential, obtaining information regarding the application
status of a healthcare institution is a subject of individual
contacts and institution's willingness to share such infor-
mation. The reviewers for the category of healthcare avail-
able through the Malcolm Baldrige list of examiners were
reached via phone and asked if they would consider shar-
ing information on the applicant status of their institu-
tions. Information was also solicited whether the
examiners' organizations had won state quality awards
within the last five years, and whether the examiners were
senior administrators in their respective institutions. If the
examiners and senior healthcare administrators qualified
as experts in healthcare quality improvement and patient
safety according to the study criteria described above, they
were invited to participate in the study. In general, the
study participants were recruited via telephone and/or let-
ter contact and were selected from (1) the list of Malcolm
Baldrige examiners, (2) senior administrators from
healthcare institutions that had won national and/or state
quality awards, and (3) referrals from (1) and (2). The
recruitment of participants was discontinued after 23
qualified individuals confirmed their willingness to serve
on the Delphi panel.
Importance rating scale
The Delphi panel utilized a four-choice Likert scale for
assessing the importance of suggested critical processes for
patient safety systems in healthcare institutions. The scale
was modelled according to the original importance scale
developed by Turoff [26]. The participants in the panel
were asked to indicate the importance of the Delphi sur-
vey items from 1 to 4, where "4" represented processes
very important to patient safety systems in healthcare insti-
tutions, and "1" represented unimportant (irrelevant). All
survey items that were identified by the expert group as
"very important" or "important" for patient safety in the
third study round, when the experts reached consensus,
were included in the final patient safety tool. The DelphiBMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
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survey concluded in three rounds with creation of a proc-
ess-centred tool for evaluating patient safety performance
and guiding strategic improvement at the institutional
level, extending the MBNQA criteria to the area of patient
safety [29].
Bootstrap study design
After the Delphi panel created the patient safety tool, the
concern about possible group bias with small expert num-
bers remained, because it has been argued that increased
group size is beneficial in Delphi surveys [27]. To study
possible differences in response characteristics and to
explore the possibility for group bias in the study group of
experts and, therefore, to assess the possible error in the
creation of the patient safety tool, we generated via com-
puter program (SPSS 12.5) two large samples of expert rat-
ings. Since the variation in expert opinions was greatest in
the first study round, encompassing the whole spectrum
of possible ratings from 1 to 4, the results from the first
survey round were utilized as the basis for computer gen-
eration of the expanded samples. The expert responses to
the survey items were randomly selected with replacement
by the computer program based on the raw data from the
first round for the actual survey experts. This resampling
technique is called bootstrap.
The bootstrap method was developed by Efron in 1979
and has found wide use in the field of applied statistics
[30]. Bootstrap is a Monte Carlo-type data augmentation
method utilizing resampling with replacement that can be
used with observed data. While Monte Carlo techniques
usually generate fictitious data, bootstrap resamples with
replacement from the original observed values and gener-
ates multiple bootstrap samples as a proxy to the inde-
pendent real sample. Each bootstrap sample is a random
sub-sample (with the same size as the original sample)
taken with replacement from the observed values. The
original sample is treated as the "virtual population" and
the sample is duplicated multiple times. The procedure
can be repeated as many times as desired. Resampling has
proven valid for any kind of data, including random and
non-random data [31]. During the last three decades, the
bootstrap resampling has been used widely in applied sta-
tistics [32].
Advantages and limitations of the bootstrap technique
Resampling (bootstrapping) of a random sample of an
unknown population is considered to model the distribu-
tion of that population, where the vaguer the knowledge
about the population distribution is, the more valuable
the bootstrapping technique proves to be [33]. Since clas-
sical statistical techniques are primarily designed for para-
metric statistics with normal distributions, the bootstrap
technique has an advantage in distributions with no con-
venient statistical formulae, overcoming the limitations of
the classical approaches in working with small sample
sizes and non-normal distributions [34]. Efron and Tib-
shirani proposed that the technique reduces the assump-
tions required to validate analysis and eliminates
theoretical calculations required to assess accuracy; its
major application is in determination of confidence inter-
vals, where 1,000 or more iterations are necessary to esti-
mate the confidence intervals [30]. The simplicity of the
method allows its application in a wide variety of studies
and is considered superior to standard statistical tests of
significance because it reduces the threat of multiple com-
parisons bias and provides information on the distribu-
tion of scores (and not parametric distributions); the
technique is not dependent on a specific nominal size
such as 5% and therefore is more accurate [34,35]. The
bootstrap technique may have limited accuracy in very
small sample sizes (n < 20), in extremely skewed distribu-
tions, and if extreme outliers are present [34].
Data manipulation
In this study, statistics for each bootstrap resample were
saved in memory and later used for estimation of sam-
pling variance, confidence intervals and assessment of
bias for the raw data [30]. The characteristics of the gener-
ated samples, when analyzed collectively are used to pro-
vide a more representative expression of the underlying
population, in this study – the population of patient
safety experts knowledgeable about the Malcolm Baldrige
framework. The hypothesis was that strict expert inclusion
criteria based on training in, and knowledge and under-
standing of the MBNQA framework in the original sample
of 23 experts would provide stability of responses, even if
the number of responses was increased by computer gen-
erated bootstrap samples.
The bootstrap samples were generated using SPSS 12.5
software. The characteristics of the SPSS 12.5 model were
as follows:
 NonLinear Regression
 MODEL PROGRAM b0 = 2
 COMPUTE PRED_ = b0
 CNLR VAR00001
 /OUTFILE='C:\DOC-
UME~1\User\LOCALS~1\Temp\spss452\SPSSFNLR.TMP'
 /PRED PRED_
¾
¾
¾
¾
¾
¾BMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
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Table 1: Comparison between statistical data for the original and augmented samples
Survey Item Data Entries Mean 95% CI 5% Trim. Mean SD
1 Participants, n = 23 3.64 3.39–3.88 3.70 .5680
Iterations, n = 1001 3.64 3.63–3.65 3.64 .1157
Iterations, n = 2001 3.64 3.63–3.64 3.64 .1172
2 Participants, n = 23 3.64 3.39–3.88 3.70 .5680
Iterations, n = 1001 3.64 3.63–3.65 3.64 .1154
Iterations, n = 2001 3.64 3.63–3.64 3.64 .1151
3 Participants, n = 23 3.46 3.12–3.79 3.55 .7820
Iterations, n = 1001 3.45 3.44–3.46 3.46 .1582
Iterations, n = 2001 3.46 3.45–3.46 3.46 .1589
4 Participants, n = 23 3.26 2.99–3.53 3.29 .6190
Iterations, n = 1001 3.26 3.26–3.27 3.27 .1257
Iterations, n = 2001 3.26 3.25–3.26 3.26 .1276
5 Participants, n = 23 3.13 2.89–3.37 3.14 .5480
Iterations, n = 1001 3.13 3.13–3.14 3.13 .1093
Iterations, n = 2001 3.13 3.13–3.14 3.13 .1133
6 Participants, n = 23 3.22 2.93–3.51 3.24 .6710
Iterations, n = 1001 3.22 3.21–3.23 3.22 .1347
Iterations, n = 2001 3.22 3.21–3.22 3.22 .1371
7 Participants, n = 23 3.11 2.85–3.36 3.12 .5950
Iterations, n = 1001 3.10 3.09–3.11 3.10 .1235
Iterations, n = 2001 3.10 3.10–3.11 3.10 .1226
8 Participants, n = 23 3.14 2.81–3.46 3.20 .7570
Iterations, n = 1001 3.14 3.13–3.14 3.14 .1505
Iterations, n = 2001 3.14 3.13–3.14 3.14 .1569
9 Participants, n = 23 3.18 2.85–3.52 3.25 .7770
Iterations, n = 1001 3.18 3.17–3.19 3.18 .1576
Iterations, n = 2001 3.18 3.18–3.19 3.19 .1580
10 Participants, n = 23 3.17 2.93–3.40 3.18 .5436
Iterations, n = 1001 3.17 2.95–3.38 3.16 .1088
Iterations, n = 2001 3.17 2.95–3.38 3.15 .1098
11 Participants, n = 23 3.30 2.95–3.66 3.39 .8220
Iterations, n = 1001 3.30 3.29–3.31 3.30 .1685
Iterations, n = 2001 3.31 3.30–3.31 3.31 .1652
12 Participants, n = 23 3.09 2.74–3.43 3.14 .7930
Iterations, n = 1001 3.09 3.08–3.10 3.09 .1600
Iterations, n = 2001 3.09 3.08–3.10 3.09 .1583
13 Participants, n = 23 2.87 2.54–3.20 2.90 .7570
Iterations, n = 1001 2.86 2.86–2.87 2.87 .1489
Iterations, n = 2001 2.87 2.86–2.88 2.87 .1528
14 Participants, n = 23 2.53 2.23–2.82 2.59 .6821
Iterations, n = 1001 2.52 2.52–2.53 2.53 .1412
Iterations, n = 2001 2.83 2.82–2.83 2.83 .1578
15 Participants, n = 23 2.83 2.49–3.16 2.86 .7780
Iterations, n = 1001 2.82 2.81–2.83 2.83 .1594
Iterations, n = 2001 2.83 2.82–2.83 2.83 .1578
16 Participants, n = 23 3.23 2.91–3.54 3.25 .7340
Iterations, n = 1001 3.23 3.22–3.24 3.23 .1495
Iterations, n = 2001 3.23 3.22–3.23 3.23 .1490
17 Participants, n = 23 3.35 3.01–3.68 3.39 .7750
Iterations, n = 1001 3.35 3.34–3.36 3.35 .1569
Iterations, n = 2001 3.35 3.34–3.36 3.35 .1557
18 Participants, n = 23 3.39 3.08–3.70 3.43 .7220
Iterations, n = 1001 3.39 3.39–3.40 3.40 .1455
Iterations, n = 2001 3.39 3.38–3.40 3.39 .1483
19 Participants, n = 23 3.33 3.01–3.65 3.42 .7390
Iterations, n = 1001 3.33 3.32–3.33 3.33 .1536
Iterations, n = 2001 3.33 3.33–3.34 3.33 .1528
20 Participants, n = 23 3.57 3.28–3.85 3.63 .6620
Iterations, n = 1001 3.57 3.56–3.58 3.57 .1318BMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
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Iterations, n = 2001 3.56 3.56–3.57 3.56 .1355
21 Participants, n = 23 2.96 2.65–3.26 3.00 .7057
Iterations, n = 1001 2.96 2.67–3.24 2.93 .1427
Iterations, n = 2001 2.96 2.68–3.23 2.95 .1384
22 Participants, n = 23 3.39 3.11–3.68 3.43 .6560
Iterations, n = 1001 3.39 3.38–3.40 3.39 .1385
Iterations, n = 2001 3.39 3.38–3.39 3.39 .1323
23 Participants, n = 23 3.30 2.95–3.66 3.39 .8220
Iterations, n = 1001 3.30 3.29–3.31 3.30 .1706
Iterations, n = 2001 3.30 3.30–3.31 3.31 .1714
24 Participants, n = 23 3.39 3.18–3.61 3.38 .4990
Iterations, n = 1001 3.39 3.39–3.40 3.39 .1024
Iterations, n = 2001 3.39 3.39–3.40 3.39 .0986
25 Participants, n = 23 3.48 3.22–3.73 3.52 .5930
Iterations, n = 1001 3.48 3.47–3.49 3.48 .1243
Iterations, n = 2001 3.47 3.47–3.48 3.48 .1195
26 Participants, n = 23 2.83 2.42–3.23 2.86 .9370
Iterations, n = 1001 2.83 2.81–2.84 2.83 .1874
Iterations, n = 2001 2.82 2.82–2.83 2.82 .1915
27 Participants, n = 23 2.89 2.61–3.18 2.93 .6670
Iterations, n = 1001 2.89 2.89–2.90 2.90 .1387
Iterations, n = 2001 2.89 2.89–2.90 2.89 .1369
28 Participants, n = 23 3.26 2.91–3.61 3.34 .8100
Iterations, n = 1001 3.26 3.25–3.27 3.27 .1744
Iterations, n = 2001 3.26 3.25–3.26 3.26 .1675
29 Participants, n = 23 2.83 2.44–3.21 2.86 .8870
Iterations, n = 1001 2.82 2.81–2.84 2.83 .1845
Iterations, n = 2001 2.83 2.82–2.84 2.83 .1814
30 Participants, n = 23 3.43 3.12–3.75 3.48 .7280
Iterations, n = 1001 3.44 3.43–3.45 3.44 .1496
Iterations, n = 2001 3.44 3.43–3.44 3.44 .1473
31 Participants, n = 23 3.09 2.74–3.43 3.14 .7930
Iterations, n = 1001 3.08 3.07–3.09 3.09 .1576
Iterations, n = 2001 3.09 3.08–3.09 3.09 .1639
32 Participants, n = 23 3.06 2.75–3.36 3.11 .7050
Iterations, n = 1001 3.05 3.04–3.06 3.05 .1500
Iterations, n = 2001 3.05 3.05–3.06 3.06 .1428
33 Participants, n = 23 3.17 2.84–3.51 3.24 .7780
Iterations, n = 1001 3.17 3.16–3.18 3.17 .1602
Iterations, n = 2001 3.17 3.17–3.18 3.18 .1579
34 Participants, n = 23 3.26 2.94–3.59 3.34 .7520
Iterations, n = 1001 3.27 3.26–3.28 3.28 .1528
Iterations, n = 2001 3.26 3.26–3.27 3.27 .1512
35 Participants, n = 23 3.39 3.11–3.68 3.43 .6560
Iterations, n = 1001 3.39 3.39–3.40 3.40 .1333
Iterations, n = 2001 3.39 3.38–3.39 3.39 .1314
36 Participants, n = 23 3.06 2.85–3.26 3.06 .4740
Iterations, n = 1001 3.06 3.05–3.07 3.06 .0991
Iterations, n = 2001 3.06 3.05–3.06 3.06 .0972
37 Participants, n = 23 3.32 3.05–3.59 3.35 .6310
Iterations, n = 1001 3.31 3.30–3.32 3.31 .1282
Iterations, n = 2001 3.31 3.31–3.32 3.31 .1294
38 Participants, n = 23 2.89 2.60–3.18 2.93 .6670
Iterations, n = 1001 2.89 2.88–2.90 2.89 .1369
Iterations, n = 2001 2.89 2.89–2.90 2.89 .1346
39 Participants, n = 23 3.22 2.90–3.54 3.24 .7360
Iterations, n = 1001 3.22 3.21–3.23 3.22 .1543
Iterations, n = 2001 3.48 3.47–3.48 3.48 .1022
40 Participants, n = 23 3.48 3.16–3.79 3.53 .7300
Iterations, n = 1001 3.48 3.47–3.49 3.48 .1519
Iterations, n = 2001 3.48 3.47–3.48 3.48 .1465
41 Participants, n = 23 3.39 3.08–3.70 3.43 .7220
Iterations, n = 1001 3.40 3.39–3.41 3.40 .1492
Table 1: Comparison between statistical data for the original and augmented samples (Continued)BMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
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Iterations, n = 2001 3.40 3.39–3.40 3.40 .1450
42 Participants, n = 23 3.65 3.44–3.86 3.67 .4870
Iterations, n = 1001 3.65 3.64–3.66 3.65 .1041
Iterations, n = 2001 3.65 3.65–3.66 3.65 .1003
43 Participants, n = 23 3.61 3.32–3.89 3.68 .6560
Iterations, n = 1001 3.61 3.60–3.62 3.61 .1338
Iterations, n = 2001 3.61 3.60–3.61 3.61 .1362
44 Participants, n = 23 3.61 3.39–3.82 3.62 .4990
Iterations, n = 1001 3.61 3.60–3.62 3.61 .1020
Iterations, n = 2001 3.61 3.60–3.61 3.61 .1036
45 Participants, n = 23 3.30 3.00–3.61 3.34 .7030
Iterations, n = 1001 3.31 3.30–3.32 3.31 .1461
Iterations, n = 2001 3.30 3.30–3.31 3.30 .1424
46 Participants, n = 23 3.43 3.07–3.80 3.53 .8430
Iterations, n = 1001 3.43 3.42–3.45 3.44 .1814
Iterations, n = 2001 3.44 3.43–3.44 3.44 .1735
47 Participants, n = 23 3.39 3.11–3.68 3.43 .6560
Iterations, n = 1001 3.39 3.38–3.40 3.39 .1306
Iterations, n = 2001 3.39 3.38–3.40 3.39 .1368
48 Participants, n = 23 3.48 3.26–3.70 3.48 .5110
Iterations, n = 1001 3.48 3.47–3.48 3.48 .1037
Iterations, n = 2001 3.48 3.47–3.48 3.48 .1022
49 Participants, n = 23 3.61 3.39–3.82 3.62 .4990
Iterations, n = 1001 3.61 3.60–3.62 3.61 .1018
Iterations, n = 2001 3.60 3.60–3.61 3.60 .1003
50 Participants, n = 23 3.26 2.94–3.59 3.29 .7520
Iterations, n = 1001 3.25 3.25–3.26 3.26 .1490
Iterations, n = 2001 3.27 3.26–3.27 3.27 .1527
51 Participants, n = 23 3.30 3.03–3.58 3.34 .6350
Iterations, n = 1001 3.31 3.30–3.31 3.31 .1313
Iterations, n = 2001 3.30 3.30–3.31 3.30 .1316
52 Participants, n = 23 3.39 3.11–3.68 3.43 .6560
Iterations, n = 1001 3.39 3.38–3.40 3.39 .1336
Iterations, n = 2001 3.39 3.39–3.40 3.39 .1325
53 Participants, n = 23 3.18 2.85–3.50 3.25 .7530
Iterations, n = 1001 3.18 3.17–3.19 3.18 .1542
Iterations, n = 2001 3.18 3.17–3.19 3.18 .1543
54 Participants, n = 23 3.18 2.85–3.50 3.25 .7530
Iterations, n = 1001 3.17 3.16–3.18 3.17 .1556
Iterations, n = 2001 3.18 3.18–3.19 3.18 .1550
Table 1: Comparison between statistical data for the original and augmented samples (Continued)BMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
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 /BOOTSTRAP 1000 [2000]
 /CRITERIA STEPLIMIT 2 ISTEP 1E+20.
More specifically, the regression routine and the subrou-
tine of nonlinear regression were employed. Once these
routines were selected, the options  feature of nonlinear
regression was invoked. The bootstrap option was selected
and the "paste" option was used to indicate the number of
bootstrap samples to be derived.
Results
The patient safety tool created by the Delphi panel was
based on the seven Malcolm Baldrige categories and
included 54 survey items (38 critical processes ranked
directly, and one indirectly defined by 16 performance
measures). For each survey item, the following inferential
statistics were derived:
- Mean (average) – the measure that represents the arith-
metic average for the group of experts
- 95% confidence interval – representing the upper and
lower limits between which 95% of the sample expert
scores will be expected to fall
- 5% trimmed mean – calculation of experts' average score
with exclusion of the highest and lowest 5% of the scores;
the difference between the mean and the trimmed mean
shows whether there are many outliers in the rankings
among the experts in the sample (real or computer gener-
ated)
- Standard deviation – describes the variability of the score
distribution.
These descriptive statistics were calculated for each of the
following three samples:
(a) original expert responses of 23 experts in healthcare
quality and patient safety (n = 23)
(b) augmented-computer-generated sample of 1000 itera-
tions of resampling and the original sample (n = 1001)
(c) augmented-computer-generated sample of 2000 itera-
tions of resampling and the original sample (n = 2001).
The results for each of the calculated statistics (for each of
the three groups of data) are presented in Table 1.
In general, the means of the expert scores per critical proc-
ess remained stable across the three data sets (one original
and two augmented); the confidence intervals of the three
samples were overlapping for each of the critical processes
with the confidence intervals in bigger samples being
more compact; the trimmed mean exhibited stability, and
the standard deviation decreased with increasing number
of experts. When the standard deviation decreases, this
indicates that the typical deviation of expert opinions has
not increased relative to the increased number of
responses. Therefore, we can conclude that the original
expert sample yielded results concerning the importance
of the critical processes in the patient safety tool that were
comparable to the results of the expanded samples.
The Delphi survey results showed stability after bootstrap
resampling data expansion. Therefore, the stability of the
results of the bootstrap data expansion validated the patient
safety strategic planning tool developed by the Delphi study on
patient safety [29].
Discussion
Application of Delphi studies in healthcare
In the field of healthcare, the Delphi method has been
used in planning for the future and formulating policies
and programs in biomedical research, behavioral
research, mental health, reproductive health, pharmacol-
ogy, services for the elderly, family planning services, acci-
dents and injuries, development of core competencies for
advanced nursing practitioners and development of clini-
cal care protocols [27,36-41]. The Delphi method, as a
useful way of identifying and measuring uncertainty, has
been widely utilized in medical and health services
research to explore issues in health services organizations,
to support design of educational programs, to define pro-
fessionals' roles, to define effects of medical staffing levels,
to develop criteria for appropriateness of clinical treat-
ment, and to make long-term projections of need for
patient care [42]. The Delphi methodology also has been
used to modify the National Board of Medical Examiners
(NBME) Medicine Subject Exam (Shelf) in order to align
the national exams with the internal medicine clerkship
curriculum developed by the Society of General Internal
Medicine (SGIM) and the Clerkship Directors in Internal
Medicine (CDIM) [43]. Consensus building through Del-
phi survey technique can contribute significantly to
broadening knowledge and effective decision making in
health and social care [22]. Furthermore, the Delphi
approach can be used as a senior management education
tool, environmental planning tool, and for comparison
with similar healthcare institutions. Putting together the
structure of a model, developmental planning and explo-
ration of policy options are among the explicit application
areas identified since the early 1970's [26]. Additionally,
the Delphi method has been used to delineate the barriers
to performance in health services and identify three types
of barriers to optimal healthcare performance: solution
development barriers, problem selection barriers, and
¾
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evaluation barriers. It has been argued that the forecasting
accuracy of Delphi studies is strongly reliable; for exam-
ple, a Delphi study with medical doctors evaluating the
forecasting application of the method, revealed that in
75% of the cases the estimated values proved to be less
than 10% different from the observed [26].
Challenges in selection of a Delphi panel
The questions arising around the formation of a Delphi
panel are typical for selection and formation of any group
– committee, task force, panel, or study group. Thus,
while panel member selection is a problem that should be
addressed, it is by no means unique to Delphi studies. It
has been argued that the amount of bias expressed by
study participants is offset by the fact that in answering the
questions each participant exhibits a standard deviation
which is comparable to, or greater than participant's indi-
vidual mean (i.e., an optimistic panellist is pessimistic in
some of his/her responses, and vice versa) [26].
The selection of criteria that would qualify an individual
to participate on the Delphi panel depends on the context,
scope and aims of the particular study. Some of the gen-
eral criteria include:
• Knowledge and practical engagement with the issue
under investigation
• Capacity and willingness to contribute to the explora-
tion of a particular problem
• Assurance that sufficient time will be dedicated to the
Delphi exercise,
• Good written communication skills
• Experts' skills and knowledge need not necessarily be
accompanied by standard academic qualifications or
degrees [44].
Delphi participants are purposefully selected to apply
their knowledge and experience to a certain issue based on
a criteria set. For example, the experts for a national two-
round Delphi study on the effectiveness and risks of coro-
nary angiography were chosen on the basis of their clini-
cal expertise, community influence, and diversity of
geographic location [45]. Since the Delphi method relies
on repeated questionnaires to the same initially selected
sample of participants, the method requires a continued
commitment from the panellists and is heavily dependant
on the time and continued involvement on the part of the
study participants. The widespread employment of elec-
tronic communications calls for consideration of the com-
puter literacy and skills of the target sample before
utilizing electronic means of communication [22]. Since
the sample size for Delphi panels has not been estab-
lished, it is important to know whether the selected Del-
phi panel for a particular study would yield stable results.
Utilization of bootstrap in healthcare research
During the last decade, the use of bootstrap data expan-
sion in healthcare research became more prominent.
Some examples of utilization of bootstrap in contempo-
rary healthcare research include: constructing confidence
intervals for treatment differences, analysing cost-effec-
tiveness in randomized controlled trials, assessing pro-
vider performance for providers with small numbers of
observed events, and studying the genetic linkages in viral
genome sequences [46-51]. There is a growing validation
of the value of bootstrap in medical statistics and an
increasing recognition that the bootstrap technique can
supplement and extend the conventional statistical think-
ing. Bootstrap can be used for calculation of confidence
intervals, hypothesis testing, linear regression and correla-
tion in variable prediction, and non-linear regression in
immunoassay techniques [33]. The bootstrap method,
with its computational simplicity and performance simi-
lar to the fully Bayesian approaches, was found to be a
very useful addition to healthcare researchers' statistical
toolkit [52].
Conclusion
Although experiments carried out in the 1950's and
1960's suggested that group error is reduced with
increased group size, the sample size for constructing a
Delphi panel is not a statistically-bound decision and
good results can be obtained by a comparatively small
group of homogenous experts [44]. However, the size of a
"small" Delphi sample has not been unequivocally estab-
lished.
The findings of this study are important because:
1. It was found that reliable outcomes could be obtained
with a Delphi panel consisting of a relatively small
number of Delphi experts (23) selected via strict inclusion
criteria. This finding is particularly important for conduct-
ing Delphi surveys in knowledge or practice fields where
the population of experts (the total number of qualifying
knowledgeable individuals) is limited. Experts who have
similar training and general understanding in the field of
interest allow for effective and reliable utilization of a small
sample from a limited number of experts in the field of
study.
2. The stability of the results from a Delphi survey con-
ducted with a small number of experts from a defined
field of study was established. It is hypothesized that Del-
phi surveys in other fields of study, conducted with a
small number of experts with similar training and knowl-BMC Medical Research Methodology 2005, 5:37 http://www.biomedcentral.com/1471-2288/5/37
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edge, would also yield reliable results. Given the fact that
the number of specialized experts in a particular field may
be limited, this study validated the stability of response
characteristics of a small expert sample from limited num-
bers of experts. Therefore, consistency of expert training
may allow utilization of small numbers of experts in fields
where many experts may be available but participation of a
limited number of experts on the Delphi panel may be more
practical.
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